Atlas Trials

Evaluate the Safety, Tolerability of BAT6026

Clinical trial NCT06094179 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06094179
Sponsor
Bio-Thera Solutions
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dermatitis, Atopic
Start date
2023-11-09
Primary completion
2026-06-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.